BPC-157 + TB-500 Blend
Also known as: BPC-157 + TB-500 Blend, Healing Stack
A combination of BPC-157 and TB-500 frequently used together in recovery research to pair localized angiogenic healing with systemic cell-migration and tissue-remodeling effects.
Last updated
Mechanism of Action
This blend combines BPC-157, which drives angiogenesis via the VEGFR2-Akt-eNOS pathway and supports local tissue repair, with TB-500, which regulates actin polymerization to enable cell migration and systemic regeneration. The two act through complementary, non-overlapping mechanisms, so researchers pair them to address both new blood vessel formation and broad cellular repair. The result is a frequently studied synergistic approach to soft-tissue recovery.
- Half-life
- Combined kinetics: BPC-157 short (hours), TB-500 systemic (days)
- Administration Routes
- subcutaneous, intramuscular
- Research Status
- Research Chemical
Reported Benefits
- Complementary mechanisms: angiogenesis plus cell migration
- Targets both local and systemic tissue repair
- Popular combination for tendon, ligament, and muscle recovery
- May reduce inflammation across injured tissue
- Convenience of a single combined preparation
Potential Side Effects
- Injection-site irritation
- Possible lethargy or head-rush (anecdotal, from TB-500 component)
- Theoretical angiogenesis/tumor concern from both peptides
- No long-term combined human safety data
Common Dosing
Research protocols often reference the individual ranges combined, e.g., ~250-500 mcg BPC-157 with ~2-2.5 mg TB-500 phased over a cycle. Educational reference only.
The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.
Contraindications
- Active or suspected malignancy (angiogenic activity)
- Pregnancy or breastfeeding
- Banned by WADA for competitive athletes
- Not approved for human use
BPC-157
A synthetic peptide fragment derived from a protein found in gastric juice, studied for its broad tissue-healing and cytoprotective effects. Popular in research for tendon, ligament, muscle, and gut repair.
TB-500
A synthetic version of the active region of Thymosin Beta-4, a naturally occurring peptide that regulates cell migration and tissue repair. Researched for recovery, flexibility, and wound healing.
GHK-Cu
A naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) widely researched for skin regeneration, collagen synthesis, and wound healing. Common in topical cosmetics.
- View
Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study
2026
- View
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
2026
- View
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
2025